Omicron News and Research

RSS

Researchers discover antibodies that neutralize omicron and other SARS-CoV-2 variants

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. These antibodies target areas of the virus spike protein that remain essentially unchanged as the viruses mutate.

28 Dec 2021

COVID isolation and quarantine period for general population shortened by CDC

Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation from 10 days for people with COVID-19 to 5 days, if asymptomatic, followed by 5 days of wearing a mask when around others.

27 Dec 2021

Uptake of COVID-19 vaccine doses increases before Christmas in England

Thousands more first and second doses were administered last week compared with the week before, as the public are today reminded that the offer of a vaccine is still available and encouraged to come forward to protect themselves against Omicron.

26 Dec 2021

UK Government to send out Get Boosted Now text messages from Boxing Day

From Boxing Day (26 December) people in the UK will receive a text message reminding them to get a booster vaccine to protect us all from the spread of the Omicron.

26 Dec 2021

Cancer patients who had breakthrough COVID-19 remain at high risk for hospitalization, death

The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.

26 Dec 2021

SARS-CoV-2 Alpha variant mutated to evade the immune system

The SARS-CoV-2 Alpha (B.1.1.7) variant mutated to evade our 'innate immune system', helping establish it as the world's first 'Variant of Concern', finds a new study led by researchers at UCL and the Quantitative Biosciences Institute, University of California San Francisco.

24 Dec 2021

Study helps explain why mRNA vaccines have been successful at preventing severe COVID-19

Washington University in St. Louis student Julian McCall receives a dose of Pfizer's mRNA-based COVID-19 vaccine.

24 Dec 2021

Omicron variant of SARS-CoV-2 manifests striking antibody evasion

A new study from Columbia researchers, in collaboration with scientists at the University of Hong Kong, adds more evidence that the omicron variant can evade the immune protection conferred by vaccines and natural infection and suggests the need for new vaccines and treatments that anticipate how the virus may soon evolve.

24 Dec 2021

Alpha variant of SARS-CoV-2 evolved mutations to evade the immune system

The Alpha variant of SARS-CoV-2-;the first "variant of concern"-;evolved mutations that allowed it to more efficiently suppress the immune system's early response to infection, according to a new study led by scientists at the University of California, San Francisco's Quantitative Biosciences Institute and University College London.

24 Dec 2021

Pfizer-BioNTech booster shot may offer better immunity than a two-dose regimen

A new study suggests that the immune response against severe acute respiratory syndrome coronavirus 2 is greater with a three-dose regimen than a two-dose regimen.

24 Dec 2021

New study provides a mutational analysis of SARS-CoV-2

A new study investigates mutational waves in structural and non-structural protein evolutions of SARS-CoV-2 to better understand the virus’s evolution and epidemiology.

24 Dec 2021

SARS-CoV-2 spreads through cell-to-cell transmission, study finds

The virus that causes COVID-19 has adopted some stealth moves to stay alive and kicking, and one secret to its success is hiding from the immune system by spreading through cell-to-cell transmission, a new study has found.

23 Dec 2021

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

One dose of Ad5-nCoV (Convidecia), a COVID-19 vaccine developed in China, is 57.5% effective against symptomatic COVID-19 and 91.7% effective against severe COVID-19 disease beginning 28 days postvaccination, according to a phase 3 randomized controlled trial published in The Lancet.

23 Dec 2021

CDC releases updated guidance for contingency and crisis management in healthcare settings

With the growing number of COVID-19 cases from the Omicron variant, and consistent with current understanding of the disease trajectory, CDC is releasing updated guidance for isolation and quarantine for healthcare workers, decreasing their isolation time after infection with COVID-19.

23 Dec 2021

Omicron News and Research

Researchers discover antibodies that neutralize omicron and other SARS-CoV-2 variants

COVID isolation and quarantine period for general population shortened by CDC

Uptake of COVID-19 vaccine doses increases before Christmas in England

UK Government to send out Get Boosted Now text messages from Boxing Day

Cancer patients who had breakthrough COVID-19 remain at high risk for hospitalization, death

SARS-CoV-2 Alpha variant mutated to evade the immune system

Study helps explain why mRNA vaccines have been successful at preventing severe COVID-19

Omicron variant of SARS-CoV-2 manifests striking antibody evasion

Alpha variant of SARS-CoV-2 evolved mutations to evade the immune system

Pfizer-BioNTech booster shot may offer better immunity than a two-dose regimen

New study provides a mutational analysis of SARS-CoV-2

SARS-CoV-2 spreads through cell-to-cell transmission, study finds

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

CDC releases updated guidance for contingency and crisis management in healthcare settings

Cryo-EM of Omicron variant reveals antibody evasion by spike-ACE2 complex

Emergency funding increased by £30 million to support arts, culture and heritage sectors during the pandemic

Allele-specific RT-qPCR assay to identify SARS-CoV-2 Omicron variant in wastewater

Omicron has enhanced infectivity that is only weakly neutralized by vaccination or prior infection

Researchers report loss of antibody potency against SARS-CoV-2 Omicron variant

Impact of the rapid spread of the SARS-CoV-2 Omicron variant in Southern Africa

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News